Test-to-Treat for Pharmacy is Here.

IS YOUR PHARMACY READY?

Operationalize Test-to-Treat in your pharmacy.

As you may have heard, the FDA has granted limited prescriptive authority to pharmacists for COVID-19 antiviral, Paxlovid. Test-to-Treat is here.

What does this really mean for pharmacy? And what’s next to operationalize Test-to-Treat within the pharmacy environment?

Hear David Pope, PharmD, CDE, Chief of Pharmacy and Shelley Hansell, EVP Client Relations & RCM Product Management in a townhall-style webinar, to discuss all of the crucial nuances involved in pharmacy’s Test-to- Treat model – including medical billing strategies.

David Pope, PharmD, CDE, Chief of Pharmacy

Shelley Hansell, EVP Client Relations & RCM Product Management

Watch the Test-to-Treat Townhall!

Tune in to hear David Pope, PharmD, CDE, EVP Innovation & Industry Relations and Shelley Hansell, EVP, Client Relations & RCM Product Management discuss what this means for pharmacy today, and the crucial next steps to operationalize test and treat in the pharmacy.

First Name*
Last Name*
Pharmacy Name*
State/Province*
Country*
Email*
Phone Number*
Which describes your pharmacy?*
Hidden
utm_source
Hidden
utm_medium
Hidden
utm_campaign
Hidden
utm_term
Hidden
utm_content
Hidden
gclid_field
Hidden
li_fat_id
Email
This field is for validation purposes and should be left unchanged.

Fill in the form to download our whitepaper.

First Name*
Last Name*
Pharmacy Name*
State/Province*
Country*
Email*
Phone Number*
Which describes your pharmacy?*
Hidden
utm_source
Hidden
utm_medium
Hidden
utm_campaign
Hidden
utm_term
Hidden
utm_content
Hidden
gclid_field
Hidden
li_fat_id
Comments
This field is for validation purposes and should be left unchanged.